期刊
DIABETES OBESITY & METABOLISM
卷 25, 期 10, 页码 3064-3067出版社
WILEY
DOI: 10.1111/dom.15180
关键词
clinical trial; diabetes complications; diabetic neuropathy; empagliflozin; linagliptin; SGLT2 inhibitor